Category: Discussion

JERSEY’S ECONOMIC DEVELOPMENT MINISTER ATTENDS CANNABIS EUROPA

JERSEY’S ECONOMIC DEVELOPMENT MINISTER ATTENDS CANNABIS EUROPA

The Economic Development Minister for Jersey, Senator Lyndon Farnham, attended Cannabis Europa this June alongside environmental and economic officers from the island, saying that Jersey could be a ’Centre for Excellence’ in the global cannabis industry.  The reason for the visit was to ensure that Jersey stays abreast of the latest developments in this emerging...

July 9, 2019August 25, 2019
POLITICAL: EUROPE’S ROLE IN THE INTERNATIONAL CANNABIS MARKET

POLITICAL: EUROPE’S ROLE IN THE INTERNATIONAL CANNABIS MARKET

Europe’s role in the international cannabis market has so far been relatively minor compared to booming industries in the US and Canada. Whilst the continent has been historically strong in the pharmaceutical sector, it has been comparatively slow to develop domestic medical cannabis markets. Having said this, there is enormous market potential in Europe, which...

June 20, 2019August 25, 2019
ANNOUNCING VALENS AS A SILVER PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING VALENS AS A SILVER PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce Valens as a Silver Partner for our London conference this June at the Southbank Centre. Valens is a British-Columbia based company specialising in extraction, testing, formulation and product developmentof medical cannabis. With partnerships across the world and plans to process in Europe under EU GMP certification, achieving the highest...

June 19, 2019August 25, 2019
EUROPEAN CANNABIS PATIENT EXPERIENCES

EUROPEAN CANNABIS PATIENT EXPERIENCES

By Bill Griffin Patients will benefit from cannabis at a consistent rate across Europe. Sadly, medical cannabis is far from harmonised at an EU level, resulting in very different patient experiences depending on which country you live in. As Cannabis Europa approaches, our correspondent, Bill Griffin, details five patient stories from across the continent, showing...

June 19, 2019August 25, 2019
HEALTH-TECH AND BIG DATA: SHAPING THE MODERN CANNABIS INDUSTRY

HEALTH-TECH AND BIG DATA: SHAPING THE MODERN CANNABIS INDUSTRY

Medical cannabis has the opportunity to be the first modern medical industry that is built with a digital-first approach. Technology is already providing ways to educate people, empower patients, fuel innovation and feedback into the product development cycle. For example, while governments struggle to develop the infrastructure for a medical cannabis industry – or indeed...

June 10, 2019August 25, 2019
CBD AND SPORT: PERMEATING THE MAINSTREAM

CBD AND SPORT: PERMEATING THE MAINSTREAM

As CBD has permeated popular consciousness, athletes across the world have shared stories about how they use CBD and cannabis products as part of their training and recovery. As sales and popularity soar, consumers and brands are pushing regulators to keep up with the industry. In January 2018, cannabidiol (commonly known as CBD) was removed...

June 4, 2019August 25, 2019
TWELVE MONTHS IN MEDICAL CANNABIS

TWELVE MONTHS IN MEDICAL CANNABIS

One year on since the inaugural Cannabis Europa in London, the landscape of the European cannabis industry has changed dramatically. This time 12 months ago, medical cannabis was still illegal in the UK, Belgium, Luxembourg, Portugal and Greece despite growing momentum behind legalisation campaigns. A YEAR IN REVIEW On 21st-22nd May 2018, over 400 industry...

May 22, 2019August 25, 2019
THE VALUE OF BEING A FIRST MOVER IN CANNABIS

THE VALUE OF BEING A FIRST MOVER IN CANNABIS

Right now, the cannabis industry is so new that being a part of it makes you a first mover by default. The paradox of being a first mover is that by definition you pave the way. Your costs are going to be higher and your resources more thinly spread. They make, and pay for, the...

May 22, 2019August 25, 2019
HOW CLOSE IS EUROPEAN HARMONISATION ON MEDICAL CANNABIS?

HOW CLOSE IS EUROPEAN HARMONISATION ON MEDICAL CANNABIS?

On the face of it, the European medical cannabis scene looks rosy – people often state that over 20 EU countries have legalised medical cannabis in some form or another. Dig a little deeper and you discover in many cases ‘some form or another’ can be a far cry from what a patient actually needs....

May 8, 2019August 25, 2019
WHAT LESSONS CAN THE MEDICAL CANNABIS INDUSTRY LEARN FROM THE PHARMACEUTICAL INDUSTRY?

WHAT LESSONS CAN THE MEDICAL CANNABIS INDUSTRY LEARN FROM THE PHARMACEUTICAL INDUSTRY?

As the medical cannabis industry blossoms in Europe, there is an urgent need to consider the cross-over between the nascent cannabis business and the established pharmaceutical industry. Growing public support for medical cannabis is pushing progressive legislation in an increasing number of countries. As Cannabis Europa Paris approaches on February 8th, we examine what knowledge...

February 1, 2019August 25, 2019
KEY QUESTIONS FOR FRENCH CANNABIS REFORM IN 2019

KEY QUESTIONS FOR FRENCH CANNABIS REFORM IN 2019

While opportunities for French cannabis policy reform looked dismal in early 2018, the French Medicine Agency’s (ANSM) recent recommendation that medical cannabis use be authorised has sparked discussion by key actors in the country. Softening State Attitudes? In this early stage of discussions on cannabis, there is little clarity on details, but it is useful...

January 17, 2019August 25, 2019
ANNOUNCING BEDROCAN AS SILVER PARTNER OF CANNABIS EUROPA PARIS

ANNOUNCING BEDROCAN AS SILVER PARTNER OF CANNABIS EUROPA PARIS

Cannabis Europa is pleased to introduce Bedrocan as a silver partner for the Paris conference on the 8th of February at Maison de la Chimie. Since 2003, Bedrocan has been producing standardised cannabis of pharmaceutical quality for the Dutch government. It’s the oldest legal company in the world, providing several chemically different cannabis varieties for...

December 21, 2018August 25, 2019
FRANCE’S MEDICINES AGENCY RECOMMENDS LEGALISING MEDICAL CANNABIS

FRANCE’S MEDICINES AGENCY RECOMMENDS LEGALISING MEDICAL CANNABIS

On 13 December, the French National Agency for Medicines and Health Products Safety (ANSM) published the first findings of its Temporary Specialist Scientific Committee (CSST) on medical cannabis since it was established on 10 September this year. The Committee found that it is “pertinent to authorise the use of medical cannabis” for patients with certain...

December 14, 2018August 25, 2019
ANNOUNCING SHIMADZU EUROPA AS SILVER PARTNER OF PARIS CONFERENCE

ANNOUNCING SHIMADZU EUROPA AS SILVER PARTNER OF PARIS CONFERENCE

Cannabis Europa is excited to announce Shimadzu as a silver partner for the London conference on June 24th and 25th at the Southbank Centre. Shimadzu is a medical equipment producer specialising in analytical instruments. The company develops cannabis testing solutions, such as potency testing and terpene profiling. “For us, it’s important to meet people, to...

December 13, 2018August 25, 2019
CANNABIS EUROPA PARIS 2019: MAISION DE LA CHIMIE

CANNABIS EUROPA PARIS 2019: MAISION DE LA CHIMIE

CANNABIS EUROPA PARIS 2019: MAISION DE LA CHIMIE France, a country with one of the highest rates of cannabis consumption in the world, is finally exploring the regulation of medical cannabis. In the last six months, the Minister of Health, Agnès Buzyn indicated that the government has admitted that France has fallen behind on research...

October 23, 2018August 25, 2019
INNOVATING WITH CANNABIS: 5 KEY TAKEAWAYS FROM CANNABIS EUROPA

INNOVATING WITH CANNABIS: 5 KEY TAKEAWAYS FROM CANNABIS EUROPA

Industry trends in Europe are heading towards a research-driven approach to cannabis and the further assertion of the drug as a medicine and a way to help people that are suffering. Kfir Kachlon, Senior Analyst and Cannabis-Tech Lead at OurCrowd writes on his experience at Cannabis Europa.  This past May at Cannabis Europa, Europe’s largest...

September 6, 2018August 25, 2019
GET THE MOST OUT OF CANNABIS EUROPA

GET THE MOST OUT OF CANNABIS EUROPA

Be curious Cannabis Europa is all about facilitating new ideas and helping you learn all you want to know about medical cannabis in Europe. No one is an expert in all areas of medical cannabis, but absorbing new knowledge about areas that you may be less familiar with can only be of benefit moving forward....

May 21, 2018August 25, 2019
KEEPING PATIENTS AT THE HEART OF POLICY

KEEPING PATIENTS AT THE HEART OF POLICY

A crucial part of any medical cannabis programme is the patients. They often play a key role in convincing governments to implement such programmes through their advocacy, and their needs and concerns are of utmost importance when it comes to deciding what kind of programme to put in place. Delegates at Cannabis Europa will have...

May 16, 2018August 25, 2019
PROMISES AND PITFALLS : MEDICAL CANNABIS AND PUBLIC HEALTH

PROMISES AND PITFALLS : MEDICAL CANNABIS AND PUBLIC HEALTH

One of the key challenges facing regulators and producers in implementing medical cannabis programmes in any jurisdiction is how to do so in a way that best promotes and protects public health.  Medical cannabis programmes come with their own unique set of public health issues to consider, more so, perhaps, than regulated recreational cannabis models. Potential...

May 11, 2018August 25, 2019
  • 1
  • 2